Collaborative publications produced during the course of

the CENTRE-PD project:

 

1. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.
Blauwendraat C, Faghri F, Pihlstrom L, Geiger JT, Elbaz A, Lesage S, Corvol JC, May P, Nicolas A, Abramzon Y, Murphy NA, Gibbs JR, Ryten M, Ferrari R, Bras J, Guerreiro R, Williams J, Sims R, Lubbe S, Hernandez DG, Mok KY, Robak L, Campbell RH, Rogaeva E, Traynor B, Chia R, Chung SJ; International Parkinson's Disease Genomics Consortium (IPDGC); COURAGE-PD Consortium, Hardy JA, Brice A, Wood NW, Houlden H, Shulman JM, Morris HR, Gasser T, Krüger R, Heutink P, Sharma M, Simón-Sánchez J, Nalls MA, Singleton AB, Scholz SW. Neurobiol Aging. 2017 May 17. pii: S0197-4580(17)30164-1.

doi: 10.1016/j.neurobiolaging.2017.05.009.

PMID: 28602509 DOI: 10.1016/j.neurobiolaging.2017.05.009

 

2. Classification of advanced stages of Parkinson's disease: translation into stratified treatments.
Krüger R, Klucken J, Weiss D, Tönges L, Kolber P, Unterecker S, Lorrain M, Baas H, Müller T, Riederer P. J Neural Transm (Vienna). 2017 Aug;124(8):1015-1027.

doi: 10.1007/s00702-017-1707-x

PMID: 28342083

 

3. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.
Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D. Front Aging Neurosci. 2016 May 27;8:121.

doi: 10.3389/fnagi.2016.00121

PMID: 27303289

PMCID: PMC4882324

 

4. [Wearable Technique for the Assessment of Parkinson Symptoms: What's the Future?].[Article in German]
Maetzler W, Krüger R, Müller T, Oertel W, Urban P, Warnecke T, Klucken J. Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S48-51.

doi: 10.1055/s-0042-102786

PMID: 27276073

 

5. Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.
Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium. Neurobiol Aging. 2017 Jan;49:217.e1-217.e4.

doi: 10.1016/j.neurobiolaging.2016.09.022

PMID: 27814993

PMCID: PMC5154911 [Available on 2018-01-01]

 

6. Cortical correlates of susceptibility to upper limb freezing in Parkinson's disease.
Scholten M, Govindan RB, Braun C, Bloem BR, Plewnia C, Krüger R, Gharabaghi A, Weiss D. Clin Neurophysiol. 2016 Jun;127(6):2386-93.

doi: 10.1016/j.clinph.2016.01.028

PMID: 27178857

 

7. Alpha-synuclein gene variants may predict neurostimulation outcome.
Weiss D, Herrmann S, Wang L, Schulte C, Brockmann K, Plewnia C, Gasser T, Sharma M, Gharabaghi A, Krüger R. Mov Disord. 2016 Apr;31(4):601-3.

doi: 10.1002/mds.26558

PMID: 26880248

 

8. Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's disease.
Wüst R, Maurer B, Hauser K, Woitalla D, Sharma M, Krüger R. Neurobiol Aging. 2016 Mar;39:217.e13-5.

doi: 10.1016/j.neurobiolaging.2015.11.025

PMID: 26778534

 

9. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
Casadei N, Sood P, Ulrich T, Fallier-Becker P, Kieper N, Helling S, May C, Glaab E, Chen J, Nuber S, Marcus K, Rapaport D, Ott T, Riess O, Krüger R, Fitzgerald JC. Hum Mol Genet. 2016 Feb 1;25(3):459-71.

doi: 10.1093/hmg/ddv485

PMID: 26604148

 

10. Validation of conversion between mini-mental state examination and montreal cognitive assessment.
Lawton M, Kasten M, May MT, Mollenhauer B, Schaumburg M, Liepelt-Scarfone I, Maetzler W, Vollstedt E, Hu MT, Berg D, Ben-Shlomo Y. Mov Disord. 2016 Apr;31(4):593-6.

doi: 10.1002/mds.26498

PMID: 26861697

PMCID: PMC4864892

 

11. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
Fitzgerald JC, Zimprich A, Carvajal Berrio DA, Schindler KM, Maurer B, Schulte C, Bus C, Hauser AK, Kübler M, Lewin R, Bobbili DR, Schwarz LM, Vartholomaiou E, Brockmann K, Wüst R, Madlung J, Nordheim A, Riess O, Martins LM, Glaab E, May P, Schenke-Layland K, Picard D, Sharma M, Gasser T, Krüger R. Brain. 2017 Sep 1;140(9):2444-2459.

doi: 10.1093/brain/awx202

PMID: 29050400

 

12. Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.
Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Sünkel U, Walter U, Wirdefeldt K, Berg D. Neuroepidemiology. 2015;45(4):282-97.

doi: 10.1159/000439221.

PMID: 26523894

 

13. Prodromal markers in Parkinson’s disease: Limitations in longitudinal studies and lessons learned.
Sebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, Stefanie Lerche, Guido Alves, Paolo Barone, Stefanie Behnke, Henk W Berendse, Bastiaan R Bloem, David Burn, Richard Dodel, Donald G Grosset, Michele Hu, Meike Kasten, Rejko Krueger, Marcello Moccia, Brit Mollenhauer, Wolfgang Oertel, Ulrike Sünkel, Uwe Walter, Karin Wirdefeldt, Inga Liepelt-Scarfone, Walter Maetzler, Daniela Berg. Frontiers in Aging Neuroscience. 2016 Jun 22; 8:147.

doi: 10.3389/fnagi.2016.00147

PMID: 27445791